University of Pennsylvania
University of Pennsylvania
Director, Joint Initiative for Metrology in Biology, Stanford University
Director of Product Management at LGC Clinical Diagnostics
Director of the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health
Senior Associate Dean for Faculty Development and Diversity, Taube Endowed Professor of Global Health and Infectious Diseases, Professor of Pediatrics and of Epidemiology and Population Health, Chief, Division of Pediatric Infectious Diseases, Stanford University School of Medicine, Medical Director, Infection Prevention and Control and Attending Physician, Lucile Packard Children's Hospital at Stanford
Global Project Manager for Sartorius
Chief Strategy Officer, Population Health, University of Washington; Director, Middle Eastern Initiatives Professor, Health Metrics Sciences Institute for Health Metrics and Evaluation
Chief Science Officer, Arkstone Medical Solutions
Professor of Practice and Vice Chair, Department of Health Services, Policy and Practice
Brown University School of Public Health
Senior Segment Marketing Manager-ADD, GenScript USA Inc
Professor, La Jolla Institute for Immunology
Professor, The Institute of Medical Science, University of Tokyo
Professor, Department of Molecular Microbiology & Immunology, Biochemistry & Molecular Biology and International Health, John Hopkins Bloomberg School of Public Health, Co-director, Center for Women's Health, Sex, and Gender Research
Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai
Associate Professor, Department of Medicine, Director, Center for Virus-Host-Innate Immunity (CVHII), Institute for Infectious and Inflammatory Diseases, Rutgers University, New Jersey Medical School Cancer Center
Professor of Medicine, Infectious Diseases Division, Department of Medicine, Emory University, Executive Director, Hope Clinic
NHMRC Research Fellow, The University of Queensland
Director of Microbiome Product Development, QIAGEN
Director, R&D, NGS Assay Technologies, QIAGEN
Manager, Clinical Sample Preparation R&D, Thermo Fisher Scientific
Staff Engineer, Systems Design, Thermo Fisher Scientific
Scientist III, Clinical Sample Preparation R&D, Thermo Fisher Scientific
Senior Manager, Global Scientific Communications, Thermo Fisher Scientific
Staff Scientist, Molecular Biology, Clinical Applications, Thermo Fisher Scientific
Director: CAPRISA, CAPRISA Professor of Global Health: Department of Epidemiology, Mailman School of Public Health, Columbia University
Group Leader, Institute of Neuropathology at the University Medical Center Hamburg-Eppendorf, UKE; Head of the Core Facility, Experimental Pathology "Mouse Patho", UKE
Associate Professor, Health Metrics Sciences, Institute for Health Metrics and Evaluation (IHME), University of Washington
Kenan Distinguished Professor of Epidemiology, Gillings School of Global Public Health and Microbiology and Immunology School of Medicine, University of North Carolina
Director, Emerging Infectious Diseases Branch Walter Reed Army Institute of Research Medical Officer, Civilian, Department of the Army, Associate Professor of Medicine, Uniformed Services University
Associate Professor, Tulane National Primate Research Center, Division of Comparative Pathology
Managing Director, Health Catalysts Group and Professor of Practice, Biomedical Diagnostics, Arizona State University
Associate Dean, Regional Campuses, Professor of Medicine, Division of Infectious Diseases, University of California, San Francisco
Epidemiologist and Population Health Scientist, Associate Professor, Department of Population Health and Disease Prevention, University of California, Irvine
Professor, David J. Freelander Chair in AIDS Research, Program in Molecular Medicine, Biochemistry & Molecular Biotechnology, University of Massachusetts Medical School
Professor of Medicine, Stanford University
Senior Scholar, Johns Hopkins Center for Health Security
Research Assistant Professor, Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Product Owner
General Manager, Specialty Diagnostics
North American Field Application Scientist Manager, GenScript USA, Inc.
Director Strategic Marketing, Genomics, QIAGEN
Director R&D, Thermo Fisher Scientific, Genetic Testing Solutions
Director of Microbiome Product Development, QIAGEN
Senior Scientist, Research and Development at QIAGEN
Professor of Microbiology and Immunology, Weill Cornell Medicine
Research Scientist, Host Response Team, Health and Biosecurity (H&B) at the Australian Centre for Disease Preparedness (ACDP) , CSIRO
Department of Medicine; Division of Pulmonary, Allergy, and Critical Care University of Alabama at Birmingham
Founder and Epidemiologist, Infectious Economics, LLC
Chief Strategy Officer, Population Health, University of Washington; Director, Middle Eastern Initiatives Professor, Health Metrics Sciences Institute for Health Metrics and Evaluation
Director of the Vanderbilt Vaccine Center, Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology
Assistant Professor, Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine Center for Vaccine Research
Lead at Auckland Genomics, University of Auckland, New Zealand
Associate Vice President, Research and Development, Laboratory Corporation of America
Director of Material Sciences, Swift Biosciences
Global Leader, NGS Product Experts, PerkinElmer
Senior Product Manager, Complete Genomics Facility, MGI
Director of Product Management, BGI
Director R&D, Thermo Fisher Scientific, Genetic Testing Solutions
Chief Scientific Officer, LGC SeraCare
Professor and Vice Chair, Pathology; Medical Director, Medical College of Wisconsin
Associate Director, Product Applications Genetic Sciences Division, Thermo Fisher Scientific
Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai
Director, LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Chief Strategy Officer, Population Health, University of Washington; Director, Middle Eastern Initiatives Professor, Health Metrics Sciences Institute for Health Metrics and Evaluation
Field Appication Scientist
Senior Research Fellow, Duke-NUS Medical School Singapore
Associate Faculty, Institute of Molecular and Cell Biology (A*STAR) Singapore
Assistant Professor of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai
Vice President and Distinguished Scientist, Illumina
Distinguished Professor and Director, The Genome Center, Genome and Biomedical Sciences Facility, University of California, Davis
CEO, IDRI; Clinical Professor of Medicine and Global Health, University of Washington; Affiliate Professor, Vaccine and Infectious Disease Division, Fred Hutch Cancer Research Center
Professor of Medicine, University of Alabama at Birmingham Director, Alabama Vaccine Research Clinic (AVRC)
Chief Development Officer, Yourgene Health
Professor of Microbiology & Immunology, Professor of Otolarynology-Head and Neck Surgery, Drexel University College of Medicine
Head of Segment Marketing, GenScript USA
Division of Infectious Diseases | University of Louisville
Chief Scientific Officer, LGC SeraCare
Director, Joint Initiative for Metrology in Biology, Stanford University
Mid-Atlantic and Southeast Biotherapeutics Solution Specialists
Peter Doherty NHMRC Early Career Fellow at the Queensland University of Technology (QUT)
PostDoc fellow at the Immunosurveillance Lab at the Francis Crick Institute
Chief Strategy Officer, Population Health, University of Washington; Director, Middle Eastern Initiatives Professor, Health Metrics Sciences Institute for Health Metrics and Evaluation
General Manager, Specialty Diagnostics
Professor of Environmental Health Sciences, Columbia University Mailman School of Public Health
Director, LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine, UCSF, Director, UCSF-Gladstone Center for AIDS Research (CFAR)
Senior Scholar, Johns Hopkins Center for Health Security
Professor, Department of Microbiology, University of Washington School of Medicine, Division Chief, Infectious Diseases and Translational Medicine, Washington National Primate Research Center
Vice President and Distinguished Scientist, Illumina, Inc.
Assistant Professor of Computer Science, Department of Bioengineering, Rice University
Bowman Professor and Head, Department of Immunobiology, Co-Director, University of Arizona Center on Aging, University of Arizona College of Medicine-Tucson
CEO Novasign GmbH, Project Lead BOKU - Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna
Distinguished Engineer
Senior Manager, Research and Business Development
VP, Research, immunoSEQ Dx
Chief Commercial Officer, Molecular Biology Systems, BV
Chief Scientific Officer, LGC SeraCare
Associate Scientific Director at LGC
Assistant Professor of Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth and Assistant Director, Clinical Genomics and Advanced Technology (CGAT) Laboratory
Founder and Managing Director of the Max Planck Bristol Centre for Minimal Biology
Professor of Pathology and Laboratory Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania
Chief Operating Officer, Quantitative Biosciences Institute (QBI)
Professor of Cellular and Molecular Pharmacology, UCSF, Principal Investigator, Gladstone Institute of Data Science and Biotechnology, Director of the Quantitative Bioscience Institute
Regents Distinguished Professor at KSU, University Distinguished Professor, Director - Center on Emerging & Zoonotic Infectious Diseases (CEZID), NIH Center of Biomedical Research Excellence
General Manager, Specialty Diagnostics
Global Market Development, Thermo Fisher Scientific
Professor, La Jolla Institute for Immunology
Life Sciences Technology Platform Metabolic Diseases Reagents Leader
Life Sciences Technology Platforms Leader, Discovery Reagents
EVP European Scientific Liaison Emulate, Inc.
Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction
Director & Professor, Immunity & Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute
Divisional VP, Biology Solutions at PerkinElmer
Flow Cytometry Specialist, Miltenyi Biotec
Professor and Vice Chair Department of Microbiology, Co-Director, Penn Center for Research on Coronaviruses and Other Emerging Pathogens Perelman school of Medicine University of Pennsylvania
Chief Strategy Officer, Population Health, University of Washington; Director, Middle Eastern Initiatives Professor, Health Metrics Sciences Institute for Health Metrics and Evaluation
Dean, Brown University School of Public Health
Medical Director & Co-Chair, Enterprise Laboratory Stewardship Committee, Enterprise Medical Operations, & Director of Microbiology, Virology, Mycology & Parasitology, Clevelaland Clinic
Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai
Chief Medical Officer, Biotia, Research Assistant Professor, Department Cell Biology/College of Medicine, SUNY Downstate Health Sciences University
Assistant Professor of Computer Science, Department of Bioengineering, Rice University
Product Manager, Thermo Fisher Scientific
Mid-Atlantic and Southeast Biotherapeutics Solution Specialists
Associate Director, Charles River Laboratories
Gobal Marketing Manager -
Translational Immunology, Miltenyi Biotec
CTO
Staff Scientist
Sr. Scientist
Clinical Microbiologist, Sunnybrook Health Sciences Centre, Associate Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
CHIEF SCIENTIFIC OFFICER AND Senior Vice President Of Research and Development, NANOSTRING TECHNOLOGIES
Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction
Assistant Professor of Medicine, Weill Medical College of Cornell University
Professor of Medicine, Division of Infectious Diseases Icahn School of Medicine at Mount Sinai
Global Technology Lead, Diagnostics, Cytiva
President and Co-Founder, DCN Diagnostics
President and CEO, Sona Nanotech
Commercial Director, Diagnostics, Avacta Life Sciences
Senior Product Leader, Cytiva
Senior Director, Molecular Applications
Senior Director, Global Scientific Affairs
General Manager, Specialty Diagnostics
Director, R&D, Sino Biological
Manager, Senior Scientist
Director, Flow Cytometry Assays & Application
Professor of Epidemiology, Director, Infectious Disease Epidemiology Certificate, Columbia University, Mailman School of Public Health
Postdoctoral Fellow at Rush University Medical Center in Chicago
Assistant Member, Arthritis and Clinical Immunology Director of Translational Informatics, Clinical Resources, Biorepository and Human Phenotyping Cores, Oklahoma Medical Research Foundation
Associate Professor and consultant physician Science for Life Laboratory, Karolinska Institutet Department of Pediatric Rheumatology, Karolinska University Hospital, Stockholm
General Manager - Genomics & Diagnostic Solutions Cytiva (formerly GE Life Sciences)
R&D Leader, Cytiva (formerly GE Healthcare Life Sciences)
Senior Field Applications Scientist, Luminex
Assistant Professor in Pathology and Laboratory Medicine at the University of Rochester Medical Center in Rochester NY
Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
Global Market Development, Thermo Fisher Scientific
Sr. Scientific Affairs Manager, Roche Diagnostic Corporation
Chief Operating Officer, CloudLIMS.com
Senior Product Manager, Complete Genomics Facility, MGI
Laboratory Director at BGI
Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
Biosearch Technologies Market Segment Manager MDx, LGC
Head of Virology Unit of KingMed Diagnostics
Deputy Director of Central Lab of DIAN Diagnostics
NACCCA Board Secretary, Clinical Fellow of UC San Francisco
Chairman of Chinese Society of Laboratory Medicine, Director of Clinical Laboratory of PLA General Hospital, Chief Physician
Pathologist (ABP-AP/CP, Hem), Vice President of ADICON Medical Laboratories
Senior Scientist of Antibody Research Group at GenScript ProBio
Manager of the Field Applications Group at GenScript USA, Inc
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Sichuan Provincial Center for Clinical Laboratories (SPCCL)
Associate Professor, Pathology, Vice Director of Clinical Laboratory Medicine Center, Shanghai General Hospital, affiliated to Shanghai Jiaotong University
Director, Division of Infectious Diseases, Craig-Weaver Professor of Pediatrics, Professor of Pathology, Microbiology & Immunology, Professor at Vanderbilt University
Product Manager, Antibody Therapeutics, Berkeley Lights, Inc.
China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai
Clinical Scientist, Author, Consultant
Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
Director, Microfluidics Product Management, Fluidigm
Chief Science Officer, Fluidigm
Global Market Development, Thermo Fisher Scientific
A novel coronavirus emerged in China in late 2019 and has since been officially named by the World Health Organization (WHO) as SARS-CoV-2. Labroots will be working to educate the community about this pathogen and the disease it causes, i.e. COVID-19, in an ongoing series of virtual events.
Our 2020 and 2021 virtual events in our ongoing Coronavirus Series, and this year's 1st event held on May 4, 2022 continue to be a tremendous success. These past events are now available for on-demand viewing on the Labroots website. Our next set of presentations will go live on October 19, 2022.
In this year’s event you can learn more about:
The virus known as SARS-CoV-2 is a member of the coronavirus family and is zoonotic in origin. It is transmissible from animals to humans and is thought to have originated in bats like several other coronaviruses. Researchers are working to learn more about how this virus made the leap from animals to humans and the potential role of an intermediate species.
The SARS-CoV-2 virus has already infected millions of people worldwide. In China, thousands have been killed, leading the World Health Organization to declare an international health emergency, one of only four that have ever been declared.
Researchers have found evidence that the virus can be transmitted by asymptomatic individuals and are working tirelessly to find ways to treat the fever, respiratory illness, cough, and breathing difficulties it causes.
This free event does not require any travel and will remain ongoing; webinars will continue to occur in the future as we find out more about this pathogen. The content will be available for unlimited, on-demand viewing and the global community will be able to interact using chat sessions and live-streaming. This seamless connectivity will be available on any desktop or mobile device so you can view, learn, and interact.
Call for Posters — Labroots seeks poster submissions from individuals, teams, laboratories, and companies for our virtual poster hall. Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster (and optional audio/video summary) and discuss results with interested colleagues across the globe through email and our networking lounge. Plan now to have your poster included in the Coronavirus Virtual Event Series and this virtual event.
The deadline for electronic submission of your poster title, abstract, and poster PDF is Friday 14th of October 2022 at 5:00 pm PT. Submission is free. Submit your abstract here.
Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this virtual event series, you can earn 1 Continuing Education credit per presentation.
Connect with us!
When you attend the event remember to use the hashtag #LRcoronavirus to follow the conversation and connect with other members of the global Coronavirus research community! Follow @Labroots on Twitter and @LabrootsInc on Facebook to connect with our team and stay up to date with the latest Trending News in Coronavirus research.